AVE ASX · Health Care

Avecho Biotechnology Ltd

Announcements, last 12 months: 45
Price sensitive, last 12 months: 16

Latest announcements

Released	Headline	Actions
21 Oct 2026, 3:40 PM	Response to ASX Price Query Price sensitive	AI summary
13 Oct 2026, 9:16 AM	Avecho to present at the Canaccord Drug and Device Confe
23 Sep 2026, 9:01 AM	Avecho to present at the ASX SMIDcaps Conference
31 Aug 2026, 9:15 AM	Avecho enters final stage of Phase III insomnia trial Price sensitive	AI summary
27 Aug 2026, 4:53 PM	Notification regarding unquoted securities - AVE
26 Aug 2026, 8:25 AM	Appendix 4D and Half-year Financial Report Price sensitive	AI summary
24 Aug 2026, 9:54 AM	Avecho strengthens BD capability with senior appointment
12 Aug 2026, 10:02 AM	Small Holding Share Sale Facility Completion
3 Aug 2026, 9:48 AM	Japanese patent granted for CBD capsule
29 Jul 2026, 9:43 AM	June 2026 Quarterly Activities Report & Appendix 4C Price sensitive	AI summary

Sign in to see all AVE announcements.

Guidance history

31 Aug 2026	No specific financial guidance provided.
29 Jul 2026	Avecho Biotechnology's Phase III insomnia trial continues as planned, with no increase in sample size required.
24 Jun 2026	No high-importance, price-sensitive financial metrics provided

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow AVE to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.